Enhancement of immunological activity of CpG ODN by chitosan gene carrier

Abstract

To investigate the enhancement of immunological activity of CpG ODN by chitosan gene carrier in mice, the effect of lymphocyte proliferation was detected in mice by using MTT, the levels of IgG and cytokines (IL-2 and IL-12) in serum were measured by ELISA and peripheral blood T lymphocyte subsets CD4⁺, CD8⁺ were analyzed by flow cytometry. Our results showed that spleen lymphocytes isolated from the CS-CpG ODN group of mice showed the strongest proliferation (SI=1.551), and the levels of IgG, IL-2 and IL-12 in serum were higher than those of other groups. Compared with the immunization with CpG ODN, the immunization with CS-CpG ODN gene carrier was more efficient in up-regulating the percentage of CD4⁺T cells and the ratio of CD4⁺/CD8⁺ of mice. It was concluded that CS gene carrier of CpG ODN was much more effective in improving immunity of CpG ODN in mice.

Keywords

chitosan / CpG ODN / gene carrier / mice / immunocompetence

References

[1] KriegA. M.. Immune effects and mechanisms of action of CpG motifs. Vaccine, 2000, 19: 618-622

[2] ChuR. S., TargoniO. S., KriegA. M., et al.. CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity. J Exp Med, 1997, 186: 1623-1631

[3] RichardsonS. C. W., KolbeH. V. J., DuncanR.. Potential of low molecular mass chitosan as a DNA delivery system: biocompatibility, body distribution and ability to complex and protect DNA. Int J Pharm, 1999, 178: 231-243

[4] JameelaS. R., KumaryT. V., LalA. V., et al.. Progesterone loaded chitosan microspheres: a long acting biodegradable controlled delivery system. J Controlled Release, 1998, 52(1/2): 17-24

[5] KriegA. M., YiA. K., MatsonS., et al.. CpG motifs in bacterial DNA trigger direct B-cell activation. Nature, 1995, 347(6522): 546-549

[6] ParwasserR. M., VabulasB., VillmowG. B., et al.. Bacterial CpG-DNA activates dendritic cells in vivo: T helper cell-independent cytotoxic T cell responses to soluble proteins. Eur J Immunol, 2000, 30: 3591-3597

[7] BallasZ. K., RasmussenW. L., KriegA. M.. Induction of NK activity in murine and human cells by CpG motifs in oligodeoxynucleotides and bacterial DNA. J Immunol, 1996, 157: 1840-1845

[8] ElkinsK. L., RhinehartT. R., StibitzS., et al.. Bacterial DNA containing CpG motifs stimulates lymphocyte-dependent protection of mice against lethal infection with intracellular bacteria. J Immunol, 1999, 162: 2291-2298

[9] WeinerG. J., LiuH. M., WooldridgeJ. E., et al.. Immunostimulatory oligodeoxynucleotides containing the CpG motif are effective as immune adjuvants in tumor antigen immunization. Proc Natl Acad Sci, 1997, 94: 10833-10837

[10] ChuR. S., TargoniO. S., KriegA. M., et al.. CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity. J Exp Med, 1997, 186: 1623-1631

[11] FangN., ChanV., MaoH. Q., et al.. Interactions of phospholipids bilayer with chitosan: effect of molecular weight and pH. Biomacromolecules, 2001, 2(4): 1161-1168

[12] CuiZ., MumperR. J.. Chitosan-based nanoparticles for topical genetic immunization. J Control Release, 2001, 75: 409-419